M. Gil

FAIRLANE, a double-blind placebo-controlled randomized phase II trial of neoadjuvant ipatasertib plus paclitaxel for early triple-negative breast cancer.

P. Nuciforo, D. Patt, L. de la Peña, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Prospective randomized trial of docetaxel versus doxorubicin in patients with metastatic breast cancer.

K. Friedrichs, S. Chan, T. Pintér, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The effects of adding zoledronic acid to neoadjuvant chemotherapy on tumour response: exploratory evidence for direct anti-tumour activity in breast cancer

R E Coleman, D. Cameron, D. Dodwell, 2010, British Journal of Cancer.